» Articles » PMID: 24778709

Current Electroconvulsive Therapy Practice and Research in the Geriatric Population

Overview
Specialty Psychiatry
Date 2014 Apr 30
PMID 24778709
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Electroconvulsive therapy (ECT) is utilized worldwide for various severe and treatment-resistant psychiatric disorders. Research studies have shown that ECT is the most effective and rapid treatment available for elderly patients with depression, bipolar disorder and psychosis. For patients who suffer from intractable catatonia and neuroleptic malignant syndrome, ECT can be life saving. For elderly patients who cannot tolerate or respond poorly to medications and who are at a high risk for drug-induced toxicity or toxic drug interactions, ECT is the safest treatment option. Organic causes are frequently associated with late-life onset of neuropsychiatric conditions, such as parkinsonism, dementia and stroke. ECT has proven to be efficacious even when these conditions are present. During the next decade, research studies should focus on the use of ECT as a synergistic therapy, to enhance other biological and psychological treatments, and prevent symptom relapse and recurrence.

Citing Articles

Efficacy of esketamine nasal spray for treatment-resistant depression: A meta-analysis of randomized controlled studies.

Ouyang Y, Li J Medicine (Baltimore). 2025; 104(9):e41495.

PMID: 40020133 PMC: 11875627. DOI: 10.1097/MD.0000000000041495.


Safety of electroconvulsive therapy in the context of physiological and medical complexity: A state-of-the art review.

Elias A, Das S, Kirkland J, Loyal S, Thomas N PCN Rep. 2025; 4(1):e70051.

PMID: 39759458 PMC: 11695668. DOI: 10.1002/pcn5.70051.


Electroconvulsive therapy for the acute management of severe agitation in dementia (ECT-AD): A modified study protocol.

Lapid M, Merrill J, Mueller M, Hermida A, Nykamp L, Andrus J PLoS One. 2024; 19(6):e0303894.

PMID: 38941338 PMC: 11213353. DOI: 10.1371/journal.pone.0303894.


A narrative review: suicide and suicidal behaviour in older adults.

Sadek J, Diaz-Piedra B, Saleh L, MacDonald L Front Psychiatry. 2024; 15:1395462.

PMID: 38800059 PMC: 11117711. DOI: 10.3389/fpsyt.2024.1395462.


Beyond the surface: analyzing etomidate and propofol as anesthetic agents in electroconvulsive therapy-A systematic review and meta-analysis of seizure duration outcomes.

Akhtar S, Saleem S, Rizvi S, Raja S, Asghar M Front Neurol. 2023; 14:1251882.

PMID: 37915381 PMC: 10616260. DOI: 10.3389/fneur.2023.1251882.


References
1.
Fink M, Rush A, Knapp R, Rasmussen K, Mueller M, Rummans T . DSM melancholic features are unreliable predictors of ECT response: a CORE publication. J ECT. 2007; 23(3):139-46. DOI: 10.1097/yct.0b013e3180337344. View

2.
Avery D, Winokur G . Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry. 1976; 33(9):1029-37. DOI: 10.1001/archpsyc.1976.01770090019001. View

3.
Tharyan P, Adams C . Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev. 2005; (2):CD000076. DOI: 10.1002/14651858.CD000076.pub2. View

4.
Kales H, DeQuardo J, Tandon R . Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 1999; 23(3):547-56. DOI: 10.1016/s0278-5846(99)00015-9. View

5.
Casamassima F, Lattanzi L, Perlis R, Litta A, Fui E, Bonuccelli U . Neuroleptic malignant syndrome: further lessons from a case report. Psychosomatics. 2010; 51(4):349-54. DOI: 10.1176/appi.psy.51.4.349. View